Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.

NCT00392288 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

528

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Ciclesonide
DRUG: Ciclesonide
DRUG: Placebo

Sponsor

AstraZeneca